NCRI 2019

The 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, took place on 3-5 November in Glasgow, UK. Watch our expert interviews from the largest cancer research conference in the UK.

Targeted screening and risk stratification of prostate cancer – updates from the IMPACT study

Producing patient-specific tumor-reactive T-cells

Chiara Cattaneo

Is age a barrier for chemotherapy?

Nicolo Battisti

Radiation on tumor antigenicity and adjuvanticity

Challenges with chemotherapy in older patients

Nicolo Battisti

The UK approach to proton beam therapy clinical trials

David Sebag-Montefiore

Other factors to consider with radiation effects on tumor antigenicity and adjuvanticity

Managing patients’ fear of cancer progression

Enthusiasm bias with novel robotic technology for surgery

Peter McCulloch

Precision medicine in gastrointestinal cancers: promise and pitfalls

Epigenetics and epitranscriptomics: from knowledge to applications

The future of proton beam therapy: assistance from European clinical trials

Robotic technology: hype or game changers?

Peter McCulloch

Colorectal cancer subtyping using a histology based approach

HER-2 conversion: a phenomenon in trastuzumab resistance

Clinical studies of obesity in oncogenesis and treatment response

Stephen Hursting